Eric Olson

Array ( [id] => 9817222 [patent_doc_number] => 08927006 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-01-06 [patent_title] => 'Methods and compositions for rapid treatment of otitis externa' [patent_app_type] => utility [patent_app_number] => 12/943810 [patent_app_country] => US [patent_app_date] => 2010-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5595 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12943810 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9806355 [patent_doc_number] => 20150018301 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-01-15 [patent_title] => 'LRRK-2-Mediated Neuronal Toxicity' [patent_app_type] => utility [patent_app_number] => 13/508180 [patent_app_country] => US [patent_app_date] => 2010-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 21400 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13508180 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10062812 [patent_doc_number] => 09101640 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-08-11 [patent_title] => 'Use of Danshensu, Notoginsenoside R1 or their combination in preparation of medicaments for preventing and treating diseases caused by microcirculation disorder' [patent_app_type] => utility [patent_app_number] => 13/505051 [patent_app_country] => US [patent_app_date] => 2010-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 7108 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13505051 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8659053 [patent_doc_number] => 20130039882 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-02-14 [patent_title] => 'METHOD TO MITIGATE INJURY FROM RADIATION EXPOSURE' [patent_app_type] => utility [patent_app_number] => 13/504585 [patent_app_country] => US [patent_app_date] => 2010-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 2380 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13504585 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10142171 [patent_doc_number] => 09174971 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-11-03 [patent_title] => 'Process for the preparation of compounds useful as inhibitors of SGLT2' [patent_app_type] => utility [patent_app_number] => 12/904233 [patent_app_country] => US [patent_app_date] => 2010-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29539 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12904233 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10032652 [patent_doc_number] => 09073959 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-07-07 [patent_title] => 'Process for the production of sucrose-6-ester' [patent_app_type] => utility [patent_app_number] => 12/901820 [patent_app_country] => US [patent_app_date] => 2010-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 10740 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 183 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12901820 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10898325 [patent_doc_number] => 08921540 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-12-30 [patent_title] => 'Low temperature, single solvent process for the production of sucrose-6-ester' [patent_app_type] => utility [patent_app_number] => 12/901808 [patent_app_country] => US [patent_app_date] => 2010-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 8853 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 100 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12901808 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8324428 [patent_doc_number] => 20120196824 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-02 [patent_title] => 'THERAPEUTIC AGENT FOR CEREBRAL INFARCTION' [patent_app_type] => utility [patent_app_number] => 13/501074 [patent_app_country] => US [patent_app_date] => 2010-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 206638 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13501074 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6038921 [patent_doc_number] => 20110091970 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-21 [patent_title] => 'METHYLATION OF ESTROGEN RECEPTOR ALPHA AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/898571 [patent_app_country] => US [patent_app_date] => 2010-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 11319 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0091/20110091970.pdf [firstpage_image] =>[orig_patent_app_number] => 12898571 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6121274 [patent_doc_number] => 20110077263 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-31 [patent_title] => 'Methods and Compositions of Toll-Like Receptor (TLR) Agonists' [patent_app_type] => utility [patent_app_number] => 12/892875 [patent_app_country] => US [patent_app_date] => 2010-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 23682 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20110077263.pdf [firstpage_image] =>[orig_patent_app_number] => 12892875 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6187032 [patent_doc_number] => 20110124853 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-26 [patent_title] => 'Conjugates and Compositions for Cellular Delivery' [patent_app_type] => utility [patent_app_number] => 12/891634 [patent_app_country] => US [patent_app_date] => 2010-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 51 [patent_figures_cnt] => 51 [patent_no_of_words] => 51654 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20110124853.pdf [firstpage_image] =>[orig_patent_app_number] => 12891634 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9074387 [patent_doc_number] => 08551965 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-10-08 [patent_title] => 'Anti-viral pyrimidine nucleoside analogues' [patent_app_type] => utility [patent_app_number] => 12/889980 [patent_app_country] => US [patent_app_date] => 2010-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9172 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12889980 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11750413 [patent_doc_number] => 09708415 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-07-18 [patent_title] => 'Esters of cellulosic materials and diacids and method of making thereof' [patent_app_type] => utility [patent_app_number] => 13/497171 [patent_app_country] => US [patent_app_date] => 2010-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5364 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13497171 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6202869 [patent_doc_number] => 20110065655 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-17 [patent_title] => 'THERAPEUTIC COMPOSITION TO TREAT LESIONS CAUSED BY HERPES SIMPLEX VIRUS' [patent_app_type] => utility [patent_app_number] => 12/884698 [patent_app_country] => US [patent_app_date] => 2010-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3964 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0065/20110065655.pdf [firstpage_image] =>[orig_patent_app_number] => 12884698 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6095127 [patent_doc_number] => 20110002858 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-06 [patent_title] => 'ORAL COMPOSITIONS FOR ABSORPTION OF PHOSPHOROUS COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 12/883498 [patent_app_country] => US [patent_app_date] => 2010-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5257 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0002/20110002858.pdf [firstpage_image] =>[orig_patent_app_number] => 12883498 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6064196 [patent_doc_number] => 20110201569 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-18 [patent_title] => 'Methods For Treating Myocardial Disorders' [patent_app_type] => utility [patent_app_number] => 12/883707 [patent_app_country] => US [patent_app_date] => 2010-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 12164 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0201/20110201569.pdf [firstpage_image] =>[orig_patent_app_number] => 12883707 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8760281 [patent_doc_number] => 08420802 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-04-16 [patent_title] => 'Polymer support' [patent_app_type] => utility [patent_app_number] => 13/496116 [patent_app_country] => US [patent_app_date] => 2010-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6871 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13496116 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5969333 [patent_doc_number] => 20110151020 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-23 [patent_title] => 'ACTIVE SUBSTANCE COMBINATION WITH GEMCITABINE FOR THE TREATMENT OF EPITHELIAL CANCER' [patent_app_type] => utility [patent_app_number] => 12/880972 [patent_app_country] => US [patent_app_date] => 2010-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 74 [patent_figures_cnt] => 74 [patent_no_of_words] => 19074 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0151/20110151020.pdf [firstpage_image] =>[orig_patent_app_number] => 12880972 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6149822 [patent_doc_number] => 20110021417 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-27 [patent_title] => 'COMPOSITIONS COMPRISING OLIGOSACCHARIDES' [patent_app_type] => utility [patent_app_number] => 12/873651 [patent_app_country] => US [patent_app_date] => 2010-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6841 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20110021417.pdf [firstpage_image] =>[orig_patent_app_number] => 12873651 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10838006 [patent_doc_number] => 08865679 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-10-21 [patent_title] => 'Use of beta-glucans against biological warfare weapons and pathogens including anthrax' [patent_app_type] => utility [patent_app_number] => 12/871541 [patent_app_country] => US [patent_app_date] => 2010-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 13 [patent_no_of_words] => 12584 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12871541 [rel_patent_id] =>[rel_patent_doc_number] =>)